M. Kraus & CO Pfizer Inc Transaction History

M. Kraus & CO

$309 Million
Q3 2024

A detailed history of M. Kraus & CO transactions in Pfizer Inc stock. As of the latest transaction made, M. Kraus & CO holds 19,145 shares of PFE stock, worth $511,937. This represents 0.18% of its overall portfolio holdings.

Number of Shares

19,145

Previous 19,195 0.26%

Holding current value

$511,937

Previous $537,000 3.17%

% of portfolio

0.18%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$27.7 - $31.39 $1,385 - $1,569	-50 Reduced 0.26%	19,145 $554,000
Q2 2024 Jul 10, 2024	SELL	$25.26 - $29.6 $5,936 - $6,956	-235 Reduced 1.21%	19,195 $537,000
Q1 2024 Apr 10, 2024	BUY	$25.89 - $29.73 $32,181 - $36,954	1,243 Added 6.83%	19,430 $539,000
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $6,401 - $8,315	-245 Reduced 1.33%	18,187 $523,000
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $78,107 - $91,299	-2,434 Reduced 11.66%	18,432 $611,000
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $16,189 - $21,076	-411 Reduced 1.93%	20,866 $851,000
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $6,721 - $8,774	161 Added 0.76%	21,277 $0
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $1,881 - $2,297	43 Added 0.2%	21,116 $924,000
Q1 2022 Apr 18, 2022	BUY	$45.75 - $56.69 $21,960 - $27,211	480 Added 2.33%	21,073 $1.09 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $29,130 - $43,181	-705 Reduced 3.31%	20,593 $1.22 Million
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $1,844 - $2,369	-47 Reduced 0.22%	21,298 $916,000
Q2 2021 Jul 21, 2021	SELL	$35.91 - $40.68 $19,822 - $22,455	-552 Reduced 2.52%	21,345 $836,000
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $4,755 - $5,363	142 Added 0.65%	21,897 $793,000
Q4 2020 Jan 13, 2021	SELL	$33.47 - $42.56 $5,020 - $6,384	-150 Reduced 0.68%	21,755 $801,000
Q3 2020 Oct 09, 2020	BUY	$31.75 - $37.25 $730 - $856	23 Added 0.11%	21,905 $804,000
Q2 2020 Jul 23, 2020	BUY	$30.12 - $36.54 $23,343 - $28,318	775 Added 3.67%	21,882 $716,000
Q1 2020 Apr 14, 2020	SELL	$27.03 - $38.62 $405 - $579	-15 Reduced 0.07%	21,107 $689,000
Q4 2019 Jan 15, 2020	SELL	$32.92 - $37.36 $4,115 - $4,670	-125 Reduced 0.59%	21,122 $828,000
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $2,144 - $2,780	66 Added 0.31%	21,247 $763,000
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $35,131 - $39,444	950 Added 4.7%	21,181 $918,000
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $112 - $123	-3 Reduced 0.01%	20,231 $859,000
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $5,770 - $6,579	-150 Reduced 0.74%	20,234 $883,000
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $3,447 - $4,181	-100 Reduced 0.49%	20,384 $898,000
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $9,069 - $9,668	-275 Reduced 1.32%	20,484 $743,000
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $8,105 - $9,403	-254 Reduced 1.21%	20,759 $737,000
Q4 2017 Jan 18, 2018	SELL	$33.26 - $35.29 $3,326 - $3,529	-100 Reduced 0.47%	21,013 $761,000
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $654,503 - $721,008	21,113	21,113 $754,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kraus & CO, based on Form 13F filings with the SEC.

News

Stay updated on M. Kraus & CO with notifications on news.

Account